Overview and Scope
Diabetic foot ulcer refers to skin soreness with full-thickness skin loss on the foot due to neuropathic and vascular complications in patients suffering from diabetes mellitus, which slowdowns the healing process of sores and makes it prone to infection. Diabetic foot ulcer treatment is used to prevent, treat, and manage foot ulcers caused in diabetic patients to avoid amputation if neglected.
Sizing and Forecast
The diabetic foot ulcer treatment market size has grown strongly in recent years. It will grow from $6.96 billion in 2023 to $7.52 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising diabetes prevalence, increased awareness and early detection, improved patient education, government initiatives and healthcare policies, multidisciplinary approach to care, wound care guidelines and protocols..
The diabetic foot ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $10.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing diabetes awareness campaigns, personalized medicine approaches, patient-centric care models, value-based healthcare initiatives, continuous medical education.. Major trends in the forecast period include technological advances in wound care products, multidisciplinary care teams, emphasis on offloading techniques, integration of bioactive dressings, cost-effective and outpatient treatment options, increased use of hyperbaric oxygen therapy..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report
Segmentation & Regional Insights
The diabetic foot ulcer treatment market covered in this report is segmented –
1) By Treatment: Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Other Treatments
2) By Ulcer Type: Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers
3) By Grade: Grade 1, Grade 2, Grade 3, Grade 4, Grade 5
4) By End-User: Hospital, Ambulatory Surgery Centre, Other End-Users
North America was the largest region in the diabetic foot ulcer treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic foot ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8082&type=smp
Major Driver Impacting Market Growth
The increased number of diabetes patients is expected to propel the growth of the diabetic foot ulcer treatment market going forward. Diabetes is a metabolic illness with a long-term course that causes elevated blood glucose levels and, over time, causes substantial harm to the heart, blood vessels, eyes, kidneys, and nerves. Diabetes is the leading cause of foot ulcers, leading to an increased demand for diabetic foot ulcer treatment. For instance, in 2022, according to Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people are suffering from diabetes which equals 11.3% of the United States population. Additionally, in December 2021, according to the International Diabetes Federation, a Belgium-based leading global diabetes community approximately 537 million adults are suffering from diabetes globally, whereas 3 out of 4 adults are in low- and middle-income countries. Therefore, the increased number of diabetes patients is driving the growth of the diabetic foot ulcer treatment market.
Key Industry Players
Major companies operating in the diabetic foot ulcer treatment market report are Coloplast A/S, Medtronic PLC, Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries Inc., ConvaTec Inc., Acelity L.P. Inc., 3M Healthcare, Smith & Nephew Plc, Organogenesis Inc., BSN Medical GMBH, Integra LifeSciences Corporation, Derma Sciences Inc., Advancis Medical, Tissue Regenix Group PLC, Osiris Therapeutics Inc., MiMedx Group Inc., ACell Inc., Kerecis, Human Regenerative Technologies LLC, Tissue Engineering Technologies AG, AOTI Inc., Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical, L&R USA Inc., Systagenix Wound Management, Wound Care Technologies Inc., Misonix Inc., Bioventus, Cellumed Co. Ltd.
The diabetic foot ulcer treatment market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
